VSee Health divested its subsidiary VSee Lab to former co-CEO Milton Chen in exchange for shares, significantly narrowing projected net losses and leaving Dr. Imoigele Aisiku as the sole CEO. Concurrently, VisionWave Holdings agreed to acquire a 52% stake in Foresight Autonomous Holdings with a two-year value protection mechanism for the shares involved. Additionally, Visionary Holdings received a Nasdaq delisting notice and plans to appeal the decision before a formal hearings panel.
